1. Introduction {#sec1-molecules-16-02304}
===============

Chalcones are synthesized by condensing ketones with aromatic aldehydes in the presence of suitable bases. They are very useful intermediates for the synthesis of five- \[[@B1-molecules-16-02304],[@B2-molecules-16-02304]\], six- \[[@B1-molecules-16-02304],[@B3-molecules-16-02304]\] and seven-membered \[[@B4-molecules-16-02304]\] heterocyclic compounds. Chalcone derivatives exhibit diverse pharmacological activities \[[@B5-molecules-16-02304],[@B6-molecules-16-02304],[@B7-molecules-16-02304],[@B8-molecules-16-02304],[@B9-molecules-16-02304],[@B10-molecules-16-02304],[@B11-molecules-16-02304],[@B12-molecules-16-02304],[@B13-molecules-16-02304],[@B14-molecules-16-02304]\]. It is therefore, not surprising that many synthetic methods have been developed for the preparation of heterocycles starting from chalcone precursors that have been tested for their antimicrobial activities.

2. Results and Discussion {#sec2-molecules-16-02304}
=========================

All of our results are shown in [**Scheme 1**](#molecules-16-02304-sch001){ref-type="scheme"}. The starting chalcones **1a--c** were obtained in good yields by a base catalyzed condensation \[[@B15-molecules-16-02304]-[@B16-molecules-16-02304]\] of appropriately substituted benzaldehydes and cyclopropylmethyl ketone \[[@B17-molecules-16-02304]\]. The method is attractive since it specifically generates the (*E*) isomer \[[@B18-molecules-16-02304]\].

The hydrazones **2a--f** were prepared by the reaction of chalcones **1a--c** with benzoyl hydrazine derivatives and were subsequently used for the syntheses of various pyrazoles **3a--f** and oxadiazoles **4a--f**. The IR spectra of these hydrazones revealed the characteristic bands for vinyl CH=CH at 1582--1617, C=N at 1616--1647, C=O at 1664--1698 and NH at 3330--3420 cm^−1^. The ^1^H-NMR spectra showed the presence of a singlet at δ = 9.97--10.82 ppm for the NH proton, a multiplet at δ = 7.17--8.45 ppm characteristic for the aromatic protons and the olefinic =C--C*H*=CH, a doublet at δ = 6.60--6.95 ppm characteristic for the olefinic =C--CH=C*H* proton. The cyclopropyl ring protons appeared as two multiplets in the range δ = 1.56--2.64 ppm (CH) and δ = 0.70--1.46 ppm (2CH~2~), respectively.

The pyrazole derivatives **3a--f** were obtained by treatment of hydrazones **2a--f** with 30% hydrochloric acid. The IR of **3a--f** showed the characteristic bands for C=C--Ar at 1519--1596, C=N at 1623--1644 and amide carbonyl band at 1660--1686 cm^−1^, while the ^1^H-NMR spectra showed a singlet at δ = 6.64--7.12 ppm for the pyrazole--C~4~--H. On the other hand, refluxing of hydrazones **2a--f** with acetic anhydride gave the corresponding dihydro-1,3,4-oxadiazole derivatives **4a--f**. The mechanism of cyclization reaction has been well studied \[[@B19-molecules-16-02304]-[@B20-molecules-16-02304]\]. The IR spectra of the dihydro-oxadiazoles **4a--f** lacked the NH, but showed a carbonyl absorption at 1667--1677 cm^−1^ for the acetyl group. Their structures were further confirmed from the ^1^H-NMR spectra which does not reveal the presence of NH signal present in the starting hydrazone **2**, moreover, the ^1^H-NMR of **4** exhibited a singlet of three protons intensity at δ = 2.10--2.16 ppm for the COCH~3~. Finally, treatment of chalcones **1a--c** with hydroxylamine hydrochloride in presence of sodium acetate produced isoxazoles **5a--c** in moderate yield. The structure of **5** was fully confirmed by spectral method. For example, the IR of **5** does not show the presence of carbonyl band characteristic for the starting chalcone **1**. The ^1^H-NMR of **5** exhibited a singlet of one proton intensity at δ = 5.42--5.69 ppm characteristic for the isoxazole--C~4~--H. Melting points, elemental analysis and spectral methods are outlined in [**Table 1**](#molecules-16-02304-t001){ref-type="table"} and [**Table 2**](#molecules-16-02304-t002){ref-type="table"}.

2.1. Antimicrobial Activity {#sec2dot1-molecules-16-02304}
---------------------------

All the synthesized heterocyclic derivatives, pyrazoles **3a--f** oxadiazoles **4a--f** and isoxazoles 5a--c were assayed for their antimicrobial activity against four test organisms: *Staphylococcus aureus* ATCC6538P, *Escherichia coli* ATCC8739, *Pseudomonas aeruginosa* ATCC9027 and *Candida albicans* ATCC2091 using rifampicin (5 μg/disc) and ampicillin (10 μg/disc) as standard drugs following agar well-diffusion method \[[@B21-molecules-16-02304]\].

The tested heterocyclic compounds showed no significant effect against *Pseudomonas aeruginosa* and *Candida albicans,* whereas they showed a potent activity against *Staphylococcus aureus* and *Escherichia coli.* The maximum activity (+ + +) (MIC = 25 μg/mL) was indicated for compounds **3a**, **3b**, **4a**, **4b** and **5a**. These results suggest that the electron-withdrawing nitro group plays a crucial role in enhancing the observed activity.

Compounds **3e**, **4c,** **4e** and **4f** showed a moderate activity (+ +) (MIC = 50 μg /mL) against *Staphylococcus*, while these compounds exhibited slight activity (+) (MIC = 75 μg/mL) against *Escherichia coli.* All other compounds were inactive towards the different strains of bacteria. The results are summarized in [**Table 3**](#molecules-16-02304-t003){ref-type="table"}.

3. Experimental {#sec3-molecules-16-02304}
===============

3.1. General {#sec3dot1-molecules-16-02304}
------------

Melting points were taken in open capillary tubes using Electrothermal apparatus 9100 ( UK ) and are uncorrected. Microanalyses were performed at Faculty of Science, Cairo University, Cairo, Egypt, using a Elementary Vario el III C, H, N, S Analyzer (Germany). IR spectra were recorded using potassium bromide disks on a Perkin-Elmer 1650 spectrophotometer (Faculty of Science, Alexandria University, Alex, Egypt). ^1^H-NMR spectra were determined on a Varian EM-390 MHz spectrophotometer, using TMS as internal standard.

3.2. General Procedure for Preparation of E-l-Cyclopropyl-3-(*p*-substituted-phenyl)-2-propenenones ***1a--c*** {#sec3dot2-molecules-16-02304}
---------------------------------------------------------------------------------------------------------------

To a cold solution of sodium hydroxide (3 g) in aqueous ethanol (50 mL, 60%), cyclopropylmethyl ketone (10 mmol), was added dropwise (30 min), while rapidly stirring and the temperature kept below 20 °C, then the desired *p*-substituted benzaldehyde (10 mmol) was added dropwise (30 min). After five hours, the mixture was left overnight in refrigerator. The separated solid was filtered, washed with water and dried, then recrystallized from ethanol as colorless needles. The physical properties and all the spectral data were as reported in the literature \[[@B17-molecules-16-02304]\].

3.3. General Procedure for Preparation of 1-Cyclopropyl-3-(*p*-substituted-phenyl)-2-propene-l-aroyl hydrazones ***2a--e*** {#sec3dot3-molecules-16-02304}
---------------------------------------------------------------------------------------------------------------------------

A solution of chalcones **1a--c** (10 mmol) in ethanol (10 mL) was refluxed with the appropriate aroyl hydrazines (10 mmol) in glacial acetic acid (2 mL) for about six hours, then the reaction mixture was poured onto crushed ice and was kept overnight at room temperature, the separated solid was filtered off, washed successively with water and dried, then recrystallized from methanol. IR and NMR data: see [**Table 1**](#molecules-16-02304-t001){ref-type="table"} and [**Table 2**](#molecules-16-02304-t002){ref-type="table"}.

3.4. General Procedure for Preparation of 1-Aroyl-3-cyclopropyl-5-(*p*-substituted-phenyl)-pyrazoles ***3a--e*** {#sec3dot4-molecules-16-02304}
----------------------------------------------------------------------------------------------------------------

A solution of the appropriate hydrazone **3a--e** (10 mmol) in 30% hydrochloric acid (15 mL) was refluxed for about two hours, the reaction mixture was concentrated, separated solid was filtered off, washed with water, dried and recrystallized from methanol. IR and NMR data: see [**Table 1**](#molecules-16-02304-t001){ref-type="table"} and [**Table 2**](#molecules-16-02304-t002){ref-type="table"}.

3.5. General Procedure for Preparation of 3-Acetyl-2-cyclopropyl-2-(*p*-substituted styryl)-5-(p-substituted phenyl)-1,3,4-oxadiazoles ***4a--e*** {#sec3dot5-molecules-16-02304}
--------------------------------------------------------------------------------------------------------------------------------------------------

A mixture of the appropriate hydrazone **2a--e** (10 mmol) and acetic anhydride (15 mL) was heated under reflux for three hours. After the reaction mixture attained room temperature, it was poured into crushed ice and the oily product deposited was decanted from water and extracted with ether. The ether layer was washed with sodium bicarbonate, followed by water, dried over anhydrous sodium sulphate and evaporated to give the corresponding oxadiazoles **4a--e** as needles. IR and NMR data: see [**Table 1**](#molecules-16-02304-t001){ref-type="table"} and [**Table 2**](#molecules-16-02304-t002){ref-type="table"}.

3.6. General Procedure for Preparation of 3-Cyclopropyl-5-(*p*-substituted Phenyl)isoxazole ***5a--c*** {#sec3dot6-molecules-16-02304}
-------------------------------------------------------------------------------------------------------

A mixture of chalcone **1a--c** (20 mmol), hydroxylamine hydrochloride (20 mmol) and sodium acetate (20 mmol) in ethanol (25 mL) was refluxed for six hours. The mixture was concentrated by distilling out the solvent under reduced pressure and poured into ice-water. The precipitate obtained was filtered, washed and recrystallized from ethanol to give isoxazole **5** as needles. IR and NMR data: see [**Table 1**](#molecules-16-02304-t001){ref-type="table"} and [**Table 2**](#molecules-16-02304-t002){ref-type="table"}.

3.7. Determination of Antimicrobial Activity {#sec3dot7-molecules-16-02304}
--------------------------------------------

All the synthesized heterocyclic compounds **3a--f**, **4a--f** and **5a--f** were tested against four different microorganisms: *Staphylococcus aureus*, *Escherichia coli*, *Pseudomonas aeruginosa* and *Candida albicans*. The *agar well-diffusion* method was applied for the determination of inhibition zone and minimum inhibitory concentration (MIC). Briefly, 0.75 mL of broth culture containing *ca.* 106 colon-forming units (CFU) per mL of the test strain was added to 75 mL of nutrient agar medium at 45 °C, mixed well, and then poured into a 15 cm sterile metallic Petri plate. The medium was allowed to solidify, and 8 mm wells were dug with a sterile metallic borer. Then, a DMSO solution of the test sample (1 mL) at 1 mg/mL was added to the respective wells. DMSO served as negative control, and the standard antimicrobial drugs rifampicin (5 μg/disc) and ampicillin (10 μg/disc) were used as positive controls. Triplicate plates of each microorganism strain were prepared and were incubated aerobically at 37 °C for 24 h. The activity was determined by measuring the diameter of zone showing complete inhibition (mm), thereby, the zones were precisely measured with the aid of a Vernier Caliper (precision 0.1 mm).The growth inhibition was calculated with reference to the positive control.

4. Conclusions {#sec4-molecules-16-02304}
==============

In summary, this work demonstrates a rapid, efficient method for synthesis of new heterocyclic compounds of pharmacological interest.

*Sample Availability:* Samples of all the compounds are available from the authors.

Scheme and Tables
=================

![Synthesis of **2a--f**, **3a--f**, **4a--f** and **5a--f**.](molecules-16-02304-sch001){#molecules-16-02304-sch001}

molecules-16-02304-t001_Table 1

###### 

Physical and analytical data of compounds, **2a--f**, **3a--f**, **4a--f** and **5a--c**.

  Compound   X       Y       Yield (%)   Mp (ºC)   Molecular Formula       Calculated %   Found %                          
  ---------- ------- ------- ----------- --------- ----------------------- -------------- --------- ------- ------- ------ -------
  **2a**     NO~2~   Me      72          181       C~20~ H~19~ N~3~ O~3~   68.77          5.44      12.03   68.71   5.39   12.09
  **2b**     NO~2~   NO~2~   79          201       C~19~ H~16~ N~4~ O~5~   60.00          4.21      14.74   60.06   4.19   14.77
  **2c**     H       H       66          166       C~19~ H~18~ N~2~ O      78.62          6.21      9.66    78.59   6.19   9.62
  **2d**     H       Me      65          180       C~20~ H~20~ O N~2~      78.95          6.58      9.21    79.01   6.49   9.28
  **2e**     OMe     Me      69          190       C~21~ H~22~ O~2~ N~2~   75.45          6.59      8.38    75.49   6.62   8.44
  **2f**     OMe     H       74          160       C~20~ H~20~ O~2~ N~2~   75.00          6.25      8.75    74.97   6.26   8.77
  **3a**     NO~2~   Me      81          183       C~20~ H~17~ O~3~ N~3~   69.16          4.90      12.10   69.22   4.87   12.08
  **3b**     NO~2~   NO~2~   92          197       C~19~ H~14~ O~5~ N~4~   60.32          3.70      14.81   60.33   3.69   14.77
  **3c**     H       H       62          159       C~19~ H~16~ O N~2~      79.17          5.56      9.72    79.21   5.53   9.71
  **3d**     H       Me      66          164       C~20~ H~18~ O N~2~      79.47          5.96      9.27    79.51   5.91   9.27
  **3e**     OMe     Me      64          171       C~21~ H~20~ O~2~ N~2~   75.90          6.02      8.43    75.93   6.06   8.51
  **3f**     OMe     H       59          180       C~20~ H~18~ O~2~ N~2~   75.47          5.66      8.81    75.52   5.60   8.86
  **4a**     NO~2~   Me      83          201       C~22~ H~21~ O~4~ N~3~   67.52          5.37      10.74   67.52   5.43   10.80
  **4b**     NO~2~   NO~2~   97          210       C~21~ H~18~ O~6~ N~4~   59.72          4.27      13.27   59.69   4.26   13.22
  **4c**     H       H       59          177       C~21~ H~20~ O~2~ N~2~   57.90          6.02      8.43    57.84   5.99   8.44
  **4d**     H       Me      58          179       C~22~ H~22~ O~2~ N~2~   76.30          6.36      8.09    76.28   6.31   8.12
  **4e**     OMe     Me      67          189       C~23~ H~24~ O~3~ N~2~   73.40          6.38      7.45    73.44   6.39   7.49
  **4f**     OMe     H       80          162       C~22~ H~22~ O~3~ N~2~   72.93          6.08      7.73    72.91   6.01   7.76
  **5a**     NO~2~   ―       54          165       C~12~ H~10~ O~3~ N~2~   62.61          4.35      12.17   62.66   4.29   12.21
  **5b**     H       ―       49          159       C~12~ H~11~ O N         77.84          5.95      7.57    77.90   5.99   7.62
  **5c**     OMe     ―       74          161       C~13~ H~13~ O~2~ N      72.56          6.05      6.51    72.60   6.01   6.48

molecules-16-02304-t002_Table 2

###### 

IR and ^1^H-NMR spectral data of compounds **2a--f**, **3a--f**, **4a--f** and **5a--c**.

  Compound   IR cm^−1^ (KBr)   ^1^H NMR (δ / ppm)^a^                                                                                  
  ---------- ----------------- ----------------------- ------ ------ ---------------- ------ ------ ------- ------------ ------------ ----------------
  **2a**     1592              1629                    1678   3420   7.36--7.91       6.72   ―      10.66   1.91--2.55   0.75--1.37   2.21
  **2b**     1617              1647                    1698   3390   7.23--8.45       6.93   ―      10.45   1.80--2.64   0.71--1.40   ―
  **2c**     1582              1616                    1664   3330   7.19--7.63       6.60   ―      9.97    1.82--2.49   0.78--1.29   ―
  **2d**     1587              1636                    1669   3336   7.29--7.82       6.71   ―      10.82   1.71--2.36   0.70--1.40   2.10
  **2e**     1601              1628                    1687   3411   7.20--7.71       6.75   ―      10.73   1.63--2.40   0.77--1.46   2.19, 3.49
  **2f**     1617              1644                    1681   3332   7.17--7.49       6.95   ―      9.99    1.56--2.59   0.78--1.16   3.42
  **3a**     1519              1629                    1670   ―      7.26--7.92 ^b^   ―      6.85   ―       1.90--2.48   0.69--1.21   2.13
  **3b**     1586              1633                    1684   ―      7.24--8.33 ^b^   ―      7.12   ―       1.76--2.66   0.80--1.36   ―
  **3c**     1556              1641                    1660   ―      7.22--7.71 ^b^   ―      6.78   ―       1.73--2.40   0.71--1.28   ―
  **3d**     1590              1644                    1678   ―      7.24--7.77 ^b^   ―      6.64   ―       1.75--2.41   0.77--1.33   2.11
  **3e**     1571              1623                    1686   ―      7.21--7.68 ^b^   ―      6.69   ―       1.66--2.39   0.71--1.33   2.10,3.44
  **3f**     1596              1633                    1664   ―      7.11--7.62 ^b^   ―      6.74   ―       1.49--2.55   0.77--1.19   3.39
  **4a**     1587              1645                    1669   ―      7.18--7.79 ^b^   ―      ―      ―       1.92--2.41   0.67--1.32   2.01, 2.16
  **4b**     1610              1646                    1667   ―      7.22--8.22 ^b^   ―      ―      ―       1.70--2.66   0.71--1.40   2.13
  **4c**     1602              1626                    1669   ―      7.16--7.75 ^b^   ―      ―      ―       1.68--2.39   0.75--1.26   2.11
  **4d**     1594              1630                    1670   ―      7.33--7.76 ^b^   ―      ―      ―       1.73--2.44   0.71--1.38   1.99, 2.13
  **4e**     1600              1633                    1677   ―      7.26--7.72 ^b^   ―      ―      ―       1.60--2.47   0.71--1.26   2.13,3.32,2.15
  **4f**     1615              1646                    1671   ―      7.25--7.51 ^b^   ―      ―      ―       1.47--2.61   0.76--1.33   3.34,2.10
  **5a**     1580              1627                    ―      ―      7.19--7.99 ^b^   ―      5.69   ―       1.82--2.51   0.71--1.36   ―
  **5b**     1571              1629                    ―      ―      7.22--7.62 ^b^   ―      5.42   ―       1.43--2.45   0.69--1.27   ―
  **5c**     1569              1633                    ―      ―      7.26--7.70 ^b^   ―      5.46   ―       1.57--2.41   0.67--1.29   3.30

^a^ Solution in DMSO-d~6~; ^b^ The chemical shift only indicates Ar--H's.

molecules-16-02304-t003_Table 3

###### 

Antibacterial activities of newly synthesized compounds 3--5.

  -------------------------------------------------------------------------
  Compound   X       Y       *Staphylococcus aureus*   *Escherichia coli*
  ---------- ------- ------- ------------------------- --------------------
  **3a**     NO~2~   Me      \+ + +                    \+ + +

  **3b**     NO~2~   NO~2~   \+ + +                    \+ + +

  **4a**     NO~2~   Me      \+ + +                    \+ + +

  **4b**     NO~2~   NO~2~   \+ + +                    \+ + +

  **5a**     NO~2~   ―       \+ + +                    \+ + +

  **3e**     OMe     Me      \+ +                      \+

  **4c**     H       H       \+ +                      \+

  **4e**     OMe     Me      \+ +                      \+

  **4f**\    OMe\    H\      \+ +\                     \+\
  **3c**\    H\      H\      ―\                        ―\
  **3d**\    H\      Me\     ―\                        ―\
  **3f**\    OMe\    H\      ―\                        ―\
  **4d**\    H\      Me\     ―\                        ―\
  **5b**\    H\      ―\      ―\                        ―\
  **5c**     OMe     ―       ―                         ―
  -------------------------------------------------------------------------

\+ + + for maximum activity, MIC = 25 μg/mL; + + for moderate activity, MIC = 50 μg/mL; +for slight activity, MIC = 75 μg/mL and -- for inactive.
